瘤微环境中的瘤相关的介酶干细胞/瘤干细胞和癌症发生
Li Sun1, Xiaoli Cao2, Baocheng Zhou3
1Department of Clinical Laboratory, Kunshan First People's Hospital, Affiliated to Jiangsu University, Kunshan, 215300, China.
Experimental hematology & oncology
|July 17, 2025
概括
与瘤相关的介质干细胞/干细胞 (TA-MSCs) 促进瘤生长和进展. 了解TA-MSC为癌症诊断,预后和治疗开发提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 介质细胞干/干细胞 (MSCs) 具有治疗潜力,因为它们具有定位,分化和免疫调节的能力.
- 瘤带来了严重的健康风险,治疗选择有限.
- 在癌症治疗中,MSCs的瘤定位能力正在被探索,但它们的作用是复杂的.
研究的目的:
- 审查存在,特征和瘤相关MSCs (TA-MSCs) 在固体瘤中的作用.
- 阐明TA-MSCs影响瘤开始和进展的机制.
- 突出TA-MSCs在癌症管理中的临床影响.
主要方法:
- 对实体瘤中MSC研究的文献综述.
- 分析TA-MSCs的起源,异质性和与瘤细胞的相互作用.
- 关于TA-MSCs对瘤微环境的贡献的综合证据.
主要成果:
- TA-MSC与正常的MSC不同,是瘤层的组成部分.
- TA-MSCs通过与瘤细胞和树皮元素的相互作用来积极促进瘤的进展.
- 有证据表明,TA-MSCs在瘤发育和发育中起作用.
结论:
- TA-MSCs代表了理解恶性瘤的新视角.
- 对TA-MSC的进一步研究对于开发新的癌症疗法至关重要.
- TA-MSC具有改善瘤诊断,预后预测和治疗策略的潜力.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.3K
15:43Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts
Published on: October 25, 2011
23.5K
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Stem Cell Niche
5.3K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.3K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
